Application Nr Approved Date Route Status External Links
BLA761092 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Revcovi Is Indicated For The Treatment Of Adenosine Deaminase Severe Combined Immune Deficiency (Ada-Scid) In Pediatric And Adult Patients. Revcovi Is A Recombinant Adenosine Deaminase Indicated For The Treatment Of Adenosine Deaminase Severe Combined Immune Deficiency (Ada-Scid) In Pediatric And Adult Patients. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Elapegademase

Comments